机构

• 合肥物质科学研究院 [7]

采集方式

• OAI收割 [7]

内容类型

• 期刊论文 [7]

发表日期

• 2022 [4]
• 2021 [3]

学科主题

筛选

浏览/检索结果: 共7条，第1-7条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Wang, Rong;  Ye, Weiwu;  Chen, Zhanhong;  Shao, Xiying;  Cao, Wenming   |  收藏  |  浏览/下载：8/0  |  提交时间：2022/12/23 Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Chen, Zhanhong;  Wang, Xiaojia;  Huang, Jian;  Zheng, Yabing;  Shao, Xiying   |  收藏  |  浏览/下载：36/0  |  提交时间：2022/12/23 Development of a new HRD algorithm which was highly associated with anthracyclinecontaining neoadjuvant chemotherapy. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Cao, Wen-Ming;  Pan, Jiani;  Wang, Xiaojia;  Lou, Feng;  Li, Mingwei   |  收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23 BRCANet: A deep hybrid network in predicting BRCA1/2 gene mutation of breast cancer with dynamic contrast-enhanced breast MRI. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Cao, Wen-Ming;  Wang, Xiaojia;  Liu, Jian;  Wang, Lili;  Zhang, Xiaodong   |  收藏  |  浏览/下载：41/0  |  提交时间：2022/12/23 Efficacy of everolimus-containing chemotherapy in HER2 negative metastatic breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wang, Rong;  Wang, Xiaojia;  Chen, Zhan-Hong;  Niu, Jin;  Huang, Yuan   |  收藏  |  浏览/下载：17/0  |  提交时间：2022/01/10 Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文  OAI收割 ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9 作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang   |  收藏  |  浏览/下载：51/0  |  提交时间：2021/06/15 Ki67  progesterone receptor  palbociclib   Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer 期刊论文  OAI收割 CANCER RESEARCH, 2021, 卷号: 81 作者:  Huang, Jian;  Shao, Xiying;  Cai, Li;  Shi, Yanxia;  Chen, Zhanhong   |  收藏  |  浏览/下载：31/0  |  提交时间：2021/04/26